This post is from a suggested group
I finished State of the Art Management of ARDS! 🚀
We invite you to join our discussion groups and engage with other professionals on the latest critical care trials and advancements. Stay up to date on healthcare breakthroughs, trends, and reviews in the world of critical care; become a part of our collaborative community today!
View groups and posts below.
This post is from a suggested group
I finished State of the Art Management of ARDS! 🚀
This post is from a suggested group
I finished Advanced Mechanical Ventilation Course! 🚀
This post is from a suggested group
I finished Evidence-based Management of Sepsis & Septic Shock! 🚀
This post is from a suggested group
In their recent article, “Stepwise Liberation from High-Flow Nasal Cannula in Acute Respiratory Failure,” published in CHEST, the authors highlight that high-flow nasal cannula (HFNC) has become a first-line therapy for patients with acute respiratory failure. They note that despite widespread use—especially since the COVID-19 pandemic—high-quality evidence guiding HFNC discontinuation remains scarce. Decisions regarding when and how to reduce flow rate, FiO₂, or both, are often left to clinicians’ discretion in the absence of standardized protocols. Prolonged HFNC support when no longer needed may result in longer ICU and hospital stays, higher healthcare costs, and reduced availability of critical resources. To address this gap, the article proposes a standardized, physiology-based stepwise approach to HFNC liberation, analogous to spontaneous breathing trials in mechanically ventilated patients, with the aim of improving care efficiency and resource utilization in hospitalized patients with acute respiratory failure. High-Flow Nasal Cannula Liberation - CHEST

This post is from a suggested group
I finished Critical Care Crash Course! 🚀
This post is from a suggested group


From the echocardiographic images:
LVOT diameter (D) = 2.56 cm
LVOT area (A) = π × (D/2)² = 3.14 × (1.28)² ≈ 5.15 cm²
LVOT VTI = 11.8 cm
This post is from a suggested group
In a randomized trial across 18 public hospitals in Kenya involving 2,180 adults with community-acquired pneumonia (CAP), patients received either standard care or standard care plus oral low-dose glucocorticoids for 10 days. By day 30, mortality was 22.6% in the glucocorticoid group and 26.0% in the standard-care group (hazard ratio 0.84; 95% CI, 0.73–0.97; P=0.02). Adverse events were similar between groups. Conclusion: Adjunctive low-dose glucocorticoids reduced mortality without increasing adverse events, even in low-resource settings.
This post is from a suggested group

I got this from one of the ICU physicians and thought to share it with you here as it is interesting, any idea?
A patient with intracranial hemorrhage.
This post is from a suggested group

Prvc mode set with tv 440 which could not be reached in tachypnic patient (rr24) with mve of 12 ,and there is diffrence in vte and vti and there is what looks like expiratory hold! Chenyne stoke breathing?brain herniation